Increased prothrombotic property as a risk factor of acute kidney injury after surgical repair of abdominal aortic aneurysm: a prospective observational study

详细信息    查看全文

• 作者：Yasushi Innami ; Nobuyuki Katori ; Katsuya Mori ; Shizuko Kosugi…
• 关键词：ADAMTS13 ; Acute kidney injury ; AKI ; Neutrophil gelatinase ; associated lipocalin ; NGAL ; Abdominal aortic aneurysm
• 刊名：Journal of Intensive Care
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：2
• 期：1
• 全文大小：1057KB
• 参考文献：1.Kopolovic I, Simmonds K, Duggan S, Ewanchuk M, Stollery DE, Bagshaw SM: Risk factors and outcomes associated with acute kidney injury following ruptured abdominal aortic aneurysm. BMC Nephrol 2013, 14:99鈥?08.PubMed Central PubMed CrossRef
  2.Wahlberg E, DiMuzio PJ, Stoney RJ: Aortic clamping during elective operations for infrarenal disease: the influence of clamping time on renal function. J Vasc Surg 2002, 36:13鈥?8.PubMed CrossRef
  3.Tallgren M, Niemi T, P枚yhi盲 R, Raininko E, Railo M, Salmenper盲 M, Lep盲ntalo M, Hynninen M: Acute renal injury and dysfunction following elective abdominal aortic surgery. Eur J Vasc Endovasc Surg 2007, 33:550鈥?55.PubMed CrossRef
  4.Ellenberger C, Schweizer A, Diaper J, Kalangos A, Murith N, Katchatourian G, Panos A, Licker M: Incidence, risk factors and prognosis of changes in serum creatinine early after aortic abdominal surgery. Intensive Care Med 2006, 32:1808鈥?816.PubMed CrossRef
  5.Aronson S, Blumenthal R: Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth 1998, 12:567鈥?86.PubMed CrossRef
  6.Lieberthal W, Nigam SK: Acute renal failure. II: experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000, 278:F1鈥揊12.PubMed
  7.Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y: Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006, 107:528鈥?34.PubMed CrossRef
  8.Claus RA, Bockmeyer CL, Budde U, Kentouche K, Sossdorf M, Hilberg T, Schneppenheim R, Reinhart K, Bauer M, Brunkhorst FM, L枚sche W: Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost 2009, 101:239鈥?47.PubMed
  9.Claus RA, Bockmeyer CL, Sossdorf M, L枚sche W: The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med 2010, 10:236鈥?48.PubMed CrossRef
  10.Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto TA, Mori T, Wanaka A, Fukui H, Fujimura Y: Localization of ADAMTS13 to the stellate cells of human liver. Blood 2005, 106:922鈥?24.PubMed CrossRef
  11.Franchini M: Thrombotic microangiopathies: an update. Hematology 2006, 11:139鈥?6.PubMed CrossRef
  12.Gando S: Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38:S35鈥揝42.PubMed
  13.Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, R11:R31.CrossRef
  14.Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H: Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost 2006, 4:2490鈥?493.PubMed CrossRef
  15.Kobayashi S, Yokoyama Y, Matsushita T, Kainuma M, Ebata T, Igami T, Sugawara G, Takahashi Y, Nagino M: Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 2012, 147:909鈥?17.PubMed CrossRef
  16.McIlroy DR, Wagener G, Lee HT: Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 2010, 112:998鈥?004.PubMed CrossRef
  17.Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E: Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001, 98:2730鈥?735.PubMed CrossRef
  18.Mannucci PM, Parolari A, Canciani MT, Alemanni F, Camera M: Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery. J Thromb Haemost 2005, 3:397鈥?99.PubMed CrossRef
  19.Lo B, Nierich AP, Kalkman CJ, Fijnheer R: Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery. Thromb Haemost 2007, 97:21鈥?6.PubMed
  20.Davies RS, Abdelhamid M, Wall ML, Vohra RK, Bradbury AW, Adam DJ: Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm. J Vasc Surg 2011, 54:865鈥?78.PubMed CrossRef
  21.Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA: Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 2005, 105:1085鈥?093.PubMed CrossRef
  22.Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, L盲mmle B: von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998, 339:1578鈥?584.PubMed CrossRef
  23.Reiter RA, Kn枚bl P, Varadi K, Turecek PL: Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 2003, 101:946鈥?48.PubMed CrossRef
  24.Mannucci PM, Capoferri C, Canciani MT: Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 2004, 126:213鈥?18.PubMed CrossRef
  25.Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S: Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 1992, 40:167鈥?70.PubMed CrossRef
  26.Martin K, Borgel D, Lerolle N, Feys HB, Trinquart L, Vanhoorelbeke K, Deckmyn H, Legendre P, Diehl JL, Baruch D: Decreased ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007, 35:2375鈥?382.PubMed
  27.Swartbol P, Truedsson L, Norgren L: Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg 1998, 28:664鈥?68.PubMed CrossRef
  28.Devarajan P: Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010, 4:265鈥?80.PubMed Central PubMed CrossRef
  29.Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C: Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444鈥?51.PubMed Central PubMed CrossRef
  30.Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R: Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol 2013, 163:514鈥?19.PubMed CrossRef
  31.Fukushima H, Nishio K, Asai H, Watanabe T, Seki T, Matsui H, Sugimoto M, Matsumoto M, Fujimura Y, Okuchi K: Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. Shock 2013, 39:409鈥?14.PubMed CrossRef
  32.Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y: Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 2008, 23:301鈥?07.PubMed CrossRef
  33.Hugenholtz GC, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT, Lisman T: An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology 2013, 58:752鈥?1.PubMed CrossRef
  34.Matsuyama T, Uemura M, Ishikawa M, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Takimura C, Fujimura Y, Fukui H: Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res 2007, 31:S27鈥?5.PubMed CrossRef
  35.Bockmeyer CL, Reuken PA, Simon TP, Budde U, L枚sche W, Bauer M, Birschmann I, Becker JU, Marx G, Claus RA: ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition. Thromb Haemost 2011, 105:145鈥?53.PubMed CrossRef
  
• 作者单位：Yasushi Innami (1)
  Nobuyuki Katori (1)
  Katsuya Mori (1)
  Shizuko Kosugi (1)
  Takeshi Suzuki (1)
  Norihiro Sakurai (1)
  Hiromasa Nagata (1)
  Junzo Takeda (1)
  Hiroshi Morisaki (1)
  
  1. Department of Anesthesiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan
  
• 刊物类别：Intensive / Critical Care Medicine;
• 刊物主题：Intensive / Critical Care Medicine;
• 出版者：BioMed Central
• ISSN：2052-0492

文摘

Background Acute kidney injury (AKI) is one of the major morbidities after surgical repair of abdominal aortic aneurysm (AAA); however, precise pathogenesis of this morbidity has not been well determined. Since prothrombotic coagulation abnormality may precede organ dysfunction in systemic inflammatory state, we examined the kinetics of von Willebrand factor (VWF) and a disintegrin-like metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13), a cleaving enzyme of VWF, on the development of AKI after AAA surgery.